PTHL (Pheton) Operatsion rentabellik

Ommaviy kompaniya Pheton Holdings Limited (PTHL) logotipi

Pheton Holdings Ltd maxsus braxiterapiya dasturiy ta'minoti orqali Xitoy shifoxonalarida o'z mavqeini saqlab qolmoqda va mintaqaviy markazlar orqali kengaymoqda. Kuchli narx belgilash imkoniyati aniq radiatsiya hisob-kitoblari uchun mo'ljallangan AI tizimlari bilan ta'minlanadi. Daromadlar onkologik rejalashtirish dasturiy ta'minoti sotuviga asoslangan. Operatsion foyda marjasi joriy samaradorlikni namoyish etmoqda, bunda oxirgi ko'rsatkich -831.10 ni tashkil etib, biznesning operatsion barqarorligini tasdiqlaydi.

Pheton Holdings Ltd (PTHL): Operatsion foyda bo'yicha sotuv rentabelligi 06.09.2024dan 16.01.2026gacha

Pheton - tahliliy kesimlar va asosiy koʻrsatkichlar (PTHL)

- biznesning bozor baholash ko'rsatkichlari:
Kompaniyaning fundamental tahlili:PTHL, Pheton Holdings
Pheton Holdings Limited tayyor mahsulotlari

Operatsion marja xarajatlarni boshqarish samaradorligini o'lchaydi va umumiy daromadga nisbatan foizlar va soliqlar to'lanishidan oldingi asosiy operatsiyalardan olingan foyda ulushini aks ettiradi. Operatsion rentabellik tendentsiyasini tahlil qilish orqali investor Pheton Holdings Ltd. (PTHL) kompaniyasida aniqlik braxiterapiyasi innovatsiyalarining monetizatsiyasi, yuqori texnologiyali saratonni davolash tizimlarini joriy etish bilan bog'liq xarajatlarni minimallashtirgan holda, qanchalik darajada haqiqiy operatsion daromadga aylanishini baholaydi.

Muhim raqobatchilar

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Operatsion rentabellik ANI Pharmaceuticals Inc|MNKD: Operatsion foyda normasi|Sotuvning operatsion marjasi AMPH (Amphastar)|PCRX - Sotuvning operatsion rentabelligi|Operatsion marja SPRY (ars-pharma.com)|Operatsion foyda normasi TBPH|Aquestive Therapeutics, Inc. - Operatsion marja|scpharmaceuticals.com - Operatsion foyda koeffitsiyenti|Tectonic (TECX) - Operatsion rentabellik|Sotuvning operatsion marjasi Tonix Pharmaceuticals Inc.|Operatsion rentabellik sxtchina.com|Sotuvning operatsion marjasi Eupraxia Pharmaceuticals (EPRX)|Operatsion marja BHST|EXOZ - Sotuvning operatsion rentabelligi|Oramed - Sotuvning operatsion marjasi|Entera Bio Ltd. (ENTX) - Sotuvning operatsion rentabelligi|HYFT - Operatsion rentabellik|ABVC: Operatsion rentabellik|CPIX: Operatsion marja|Quantum BioPharma Ltd. - Operatsion foyda normasi|FGEN (FibroGen Corp) - Operatsion marja|Telomir Pharma (TELO) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operatsion foyda normasi|Operatsion rentabellik Rallybio Corporation RLYB|LEXX: Operatsion foyda bo'yicha sotuv rentabelligi|PULM - Operatsion rentabellik|Operatsion foyda marjasi APM|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.